Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03SJY
|
|||
| Former ID |
DNC007893
|
|||
| Drug Name |
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]undecanamide
|
|||
| Synonyms |
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]undecanamide; CHEMBL394635; BDBM22994; N-arachidonoylserotonin analogue, 1g
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H32N2O2
|
|||
| Canonical SMILES |
CCCCCCCCCCC(=O)NCCC1=CNC2=C1C=C(C=C2)O
|
|||
| InChI |
1S/C21H32N2O2/c1-2-3-4-5-6-7-8-9-10-21(25)22-14-13-17-16-23-20-12-11-18(24)15-19(17)20/h11-12,15-16,23-24H,2-10,13-14H2,1H3,(H,22,25)
|
|||
| InChIKey |
RNYSECALLZNZML-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Inflammatory mediator regulation of TRP channels | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
| Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
| Reactome | TRP channels | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. J Med Chem. 2007 Dec 27;50(26):6554-69. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.